NICE (NASDAQ:NICE – Free Report) had its price objective cut by Northland Securities from $305.00 to $275.00 in a research report released on Friday, Benzinga reports. They currently have an outperform rating on the technology company’s stock.
A number of other equities analysts also recently weighed in on NICE. William Blair reaffirmed an outperform rating on shares of NICE in a research report on Wednesday, June 12th. Bank of America lowered their price objective on NICE from $300.00 to $270.00 and set a buy rating on the stock in a research report on Friday, May 17th. Barclays cut their price target on NICE from $320.00 to $286.00 and set an overweight rating on the stock in a research note on Thursday, July 25th. StockNews.com downgraded NICE from a strong-buy rating to a buy rating in a research report on Friday, June 14th. Finally, Royal Bank of Canada lowered their price objective on NICE from $265.00 to $230.00 and set an outperform rating for the company in a research report on Wednesday, June 12th. Sixteen research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has a consensus rating of Buy and an average price target of $269.64.
View Our Latest Stock Analysis on NICE
NICE Price Performance
NICE (NASDAQ:NICE – Get Free Report) last issued its quarterly earnings data on Thursday, August 15th. The technology company reported $2.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.58 by $0.06. NICE had a return on equity of 14.05% and a net margin of 14.92%. The business had revenue of $664.40 million during the quarter, compared to analyst estimates of $664.10 million. During the same period in the previous year, the firm earned $1.63 EPS. NICE’s quarterly revenue was up 14.3% compared to the same quarter last year. Sell-side analysts predict that NICE will post 8.4 EPS for the current fiscal year.
Institutional Investors Weigh In On NICE
A number of hedge funds have recently added to or reduced their stakes in the business. Capital Research Global Investors increased its holdings in NICE by 4.0% in the first quarter. Capital Research Global Investors now owns 5,181,366 shares of the technology company’s stock worth $1,350,367,000 after purchasing an additional 201,035 shares in the last quarter. Capital International Investors increased its holdings in NICE by 16.2% in the fourth quarter. Capital International Investors now owns 2,135,753 shares of the technology company’s stock worth $426,402,000 after purchasing an additional 298,112 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd increased its holdings in NICE by 171.2% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,434,450 shares of the technology company’s stock worth $286,564,000 after purchasing an additional 905,612 shares in the last quarter. William Blair Investment Management LLC increased its holdings in shares of NICE by 12.3% during the first quarter. William Blair Investment Management LLC now owns 1,364,561 shares of the technology company’s stock valued at $355,631,000 after acquiring an additional 149,149 shares in the last quarter. Finally, Black Creek Investment Management Inc. increased its holdings in shares of NICE by 22.6% during the second quarter. Black Creek Investment Management Inc. now owns 1,356,775 shares of the technology company’s stock valued at $233,325,000 after acquiring an additional 250,334 shares in the last quarter. 63.34% of the stock is currently owned by institutional investors.
NICE Company Profile
NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing.
Recommended Stories
- Five stocks we like better than NICE
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- Find and Profitably Trade Stocks at 52-Week Lows
- 2 Option Strategies to Maximize Profits in a Bear Market
- Profitably Trade Stocks at 52-Week Highs
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for NICE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NICE and related companies with MarketBeat.com's FREE daily email newsletter.